Last $38.47 USD
Change Today +0.22 / 0.58%
Volume 640.4K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 4:30 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David Lawrence M.B.A.

Chief of Business Operations, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56$1,204,121
As of Fiscal Year 2013

Background*

Mr. David Lawrence, M.B.A., has been the Chief of Business Operations at Acorda Therapeutics, Inc. since October 2013. Mr. Lawrence serves as Founding Member and Treasurer of The Brian Ahearn Children's Fund. He served as the Chief Financial Officer of Acorda Therapeutics, Inc. since January 2005 and served as its Principal Accounting Officer. He joined Acorda Therapeutics Inc. as Vice President, Finance in 1999. From 1991 to 1999, Mr. Lawrence held several positions ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
Roger Williams University
MBA
Iona College

Other Affiliations*

Annual Compensation*

Salary$312,689
Total Annual Compensation$312,689

Stock Options*

Restricted Stock Awards$221,503
All Other Compensation$7,650
Exercisable Options258,290
Unexercisable Options60,055
Total Number of Options318,345

Total Compensation*

Total Annual Cash Compensation$447,412
Total Short Term Compensation$312,689
Other Long Term Compensation$229,153
Total Calculated Compensation$1,204,121
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $38.47 USD +0.22

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
Keith A. Katkin Chief Executive Officer, President, Director, Member of Executive Committee and Member of Pricing Committee
Avanir Pharmaceuticals, Inc.
$611.8K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Uli Hacksell Ph.D.Chief Executive Officer, President and Director
ACADIA Pharmaceuticals Inc.
$935.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.